Resumen de Investigación
Analyzed using Evidence Intelligence™

Educational Visits Improve Metformin Prescribing for Type 2 Diabetes

Última actualización 5 de julio de 2026

Key finding

The use of metformin increased by 5.9% after the individual AD visit.

This study evaluated the impact of academic detailing and group visits on prescribing practices for Type 2 Diabetes, finding significant increases in metformin and insulin prescriptions.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Long-Term (1–5 y)

Risk of bias

Some Concerns

Guarda este estudio en tu Evidence Tracker para encontrarlo facilmente cuando lo necesites.

Plain-language summary

What this paper says

A plain-language read of the study's main message and where it applies.

Study focus

This study evaluated the impact of academic detailing and group visits on prescribing practices for Type 2 Diabetes, finding significant increases in metformin and insulin prescriptions.

Clinical relevance

Improving prescribing practices for Type 2 Diabetes is crucial for patient management and outcomes. The significant increases in medication prescriptions following targeted interventions suggest that educational strategies can effectively enhance clinical practice and patient care.

Keep in mind

The study's effectiveness remains unclear due to limited data on long-term outcomes. The sample size and demographic diversity may limit generalizability. The control group did not receive any intervention, which may affect comparative results.

Published in

Referencia de la Revista

Publication details and source links for this paper.

Harald CL, Øyvind S, Roar D, Hege SB, Olav S. Impact of Academic Detailing and Group Visits on Prescribing for Type 2 Diabetes: A Randomized Controlled Trial. Journal of General Internal Medicine. 2024;39(16):3243-3252. doi:10.1007/s11606-024-09014-z

Efectos Principales

Metformin prescribing increased by 5.9% after the individual AD visit (p=0.006).

Insulin prescribing increased by 19.1% after the group meeting (p=0.001).

GLP-1 analogues prescribing increased by 32.2% after the group meeting.

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Group Meeting, Individual Academic Detailing Visit and GLP-1, Insulin Prescribing, Metformin Prescribing, and 1 more.

This study contributes evidence to

Primary intervention

Group Meeting

Primary outcomes

  • GLP-1
  • Insulin Prescribing
  • Metformin Prescribing

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

8
Evidence pairs
8
Relationships
0
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 50

0

Related topics

8

Evidence pairs

0

Related studies

Why it is useful

  • Contributes to 8 evidence relationships
  • Includes primary outcome data
  • Linked to 0 direct semantic evidence topics

Core evidence

Study findings

The primary outcomes reported in this study.

GLP-1

Group Meeting → GLP-1

Group Meeting → GLP-1

Evidence Intelligence™
ImpactScore™
100
Very Positive
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Insulin Prescribing

Group Meeting → Insulin Prescribing

Group Meeting → Insulin Prescribing

Evidence Intelligence™
ImpactScore™
100
Very Positive
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Metformin Prescribing

Group Meeting → Metformin Prescribing

Group Meeting → Metformin Prescribing

Evidence Intelligence™
ImpactScore™
100
Very Positive
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Total T2D Drugs Prescribing

Group Meeting → Total T2D Drugs Prescribing

Group Meeting → Total T2D Drugs Prescribing

Evidence Intelligence™
ImpactScore™
100
Very Positive
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

GLP-1

Individual Academic Detailing Visit → GLP-1

Individual Academic Detailing Visit → GLP-1

Evidence Intelligence™
ImpactScore™
100
Very Positive
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Insulin Prescribing

Individual Academic Detailing Visit → Insulin Prescribing

Individual Academic Detailing Visit → Insulin Prescribing

Evidence Intelligence™
ImpactScore™
100
Very Positive
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Metformin Prescribing

Individual Academic Detailing Visit → Metformin Prescribing

Individual Academic Detailing Visit → Metformin Prescribing

Evidence Intelligence™
ImpactScore™
100
Very Positive
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Total T2D Drugs Prescribing

Individual Academic Detailing Visit → Total T2D Drugs Prescribing

Individual Academic Detailing Visit → Total T2D Drugs Prescribing

Evidence Intelligence™
ImpactScore™
100
Very Positive
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Build your personal Evidence Workspace

Create a free account to save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.

Today's Activity

Your Evidence Workspace

Free account

Saved this study

Your free account becomes your personal diabetes evidence workspace.

Evidence Tracker

12 tracked topics

Saved Studies

48 studies

Research Notes

Coming Soon

Weekly Evidence Digest

Coming Soon

evidence suggest

La Evidencia Sugiere

  • Metformin prescribing rose by 5.9% after individual visits.
  • Insulin prescriptions increased by 19.1% following group meetings.
  • GLP-1 analogue prescribing increased by 32.2% after group meetings.
who this applies

A quién se aplica

  • Adults diagnosed with Type 2 Diabetes.
  • Healthcare providers involved in diabetes management.
keep in mind

Tener en Cuenta

  • The study's findings may not apply to all healthcare settings.
  • The impact of interventions on long-term patient outcomes is not fully assessed.
  • Variability in provider engagement during interventions could influence results.
between the lines

Entre Líneas

  • The study's effectiveness remains unclear due to limited data on long-term outcomes.
  • The sample size and demographic diversity may limit generalizability.
  • The control group did not receive any intervention, which may affect comparative results.

Save this study

Keep this study in your Evidence Tracker so you can easily find it again whenever you need it.

Today's Activity

Your Evidence Workspace

Free account

Saved this study

Your free account becomes your personal diabetes evidence workspace.

Evidence Tracker

12 tracked topics

Saved Studies

48 studies

Research Notes

Coming Soon

Weekly Evidence Digest

Coming Soon

Already have an account?

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Group Meeting and GLP-1, Group Meeting and Insulin Prescribing.

Relaciones de evidencia relacionadas

Explore in Evidence Archive

This study contributes to the evidence on the following intervention-outcome relationships.

Behavioral & Lifestyle
Detailed evidence

Group Meeting → GLP-1

Behavioral & Lifestyle

Evidence Intelligence™
ImpactScore™
100
Very Positive
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
View evidence

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Group Meeting improve glp-1?

Emerging Evidence

Group Meeting appears to improve GLP-1.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    GLP-1

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Group Meeting improve insulin prescribing?

Emerging Evidence

Group Meeting appears to improve Insulin Prescribing.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Insulin Prescribing

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Group Meeting improve metformin prescribing?

Emerging Evidence

Group Meeting appears to improve Metformin Prescribing.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Metformin Prescribing

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Group Meeting improve total t2d drugs prescribing?

Emerging Evidence

Group Meeting appears to improve Total T2D Drugs Prescribing.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Total T2D Drugs Prescribing

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, archive views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.